| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
5 companies
Hack Andrew A. F. is a Director at Atea Pharmaceuticals, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 7 buys and 7 sells.
Estimated insider holdings value: $191.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2021 | Director | Buy | 250,000 | $18.36 | $4,590,000.00 | +2.4% | ||
| Nov 3, 2020 | AVIR Atea Pharmaceuticals, Inc. | Director | Buy | 250,000 | $24.00 | $6,000,000.00 | +4.7% | |
| May 27, 2020 | DVAX Dynavax Technologies Corp | Director | Buy | 1,000,000 | $5.00 | $5,000,000.00 | +13.3% | |
| Apr 7, 2020 | Director | Buy | 3,445,667 | $5.99 | $20,649,462.58 | +123.1% | ||
| Feb 4, 2019 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 6,895 | $21.39 | $147,484.05 | -100% | |
| Jan 4, 2019 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 7,000 | $22.48 | $157,360.00 | -100% | |
| Nov 23, 2018 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 5,284 | $28.15 | $148,738.76 | -98.1% | |
| Oct 26, 2018 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 6,000 | $25.70 | $154,200.00 | -100% | |
| Sep 28, 2018 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 8,000 | $32.08 | $256,640.00 | -100% | |
| Aug 31, 2018 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $32.23 | $322,300.00 | -100% |